Mc. Heinrich et al., DNA CROSS-LINKER-INDUCED G2 M ARREST IN GROUP-C FANCONI-ANEMIA LYMPHOBLASTS REFLECTS NORMAL CHECKPOINT FUNCTION/, Blood, 91(1), 1998, pp. 275-287
Cells from individuals with Fanconi anemia (FA) arrest excessively in
the G2/M cell cycle compartment after exposure to low doses of DNA cro
ss linking agents. The relationship of this abnormality to the fundame
ntal genetic defect in such cells is unknown, but many investigators h
ave speculated that the various FA genes directly regulate cell cycle
checkpoints. We tested the hypothesis that the protein encoded by the
FA group C complementing gene (FAG) functions to control a cell cycle
checkpoint and that cells from group C patients (FA[C]) have abnormali
ties of cell cycle regulation directly related to the genetic mutation
. We found that retroviral transduction of FA(C) lymphoblasts with wil
d-type FAC cDNA resulted in normalization of the cell cycle response t
o low-dose mitomycin C (MMC). However, when DNA damage was quantified
in terms of cytogenetic damage or cellular cytotoxicity, we found simi
lar degrees of G2/M arrest in response to equitoxic amounts of MMC in
FA(C) cells as well as in normal lymphoblasts. Similar results were ob
tained using isogenic pairs of uncorrected, FAC or mock-corrected (neo
only) FA(C) cell lines. To test the function of other checkpoints we
examined the effects of hydroxyurea (HU) and ionizing radiation on cel
l cycle kinetics of FA(C) and normal lymphoblasts as well as with isog
enic pairs of uncorrected, FAG-corrected, or mock-corrected FA(C) cell
lines. In all cases the cell cycle response of FA(C) and normal lymph
oblasts to these two agents were identical. Based on these studies we
conclude that the aberrant G2/M arrest that typifies the response of F
A(C) cells to low doses of cross-linking agents does not represent an
abnormal cell cycle response but instead represents a normal cellular
response to the excessive DNA damage that results in FA(C) cells follo
wing exposure to low doses of cross-linking agents. (C) 1998 by The Am
erican Society of Hematology.